Navigation Links
Scientists Identify New Breast Cancer Gene

US researchers say that they have identified a gene that needs to be investigated as a possible breast cancer gene in future studies.

The gene detected by the researchers is Rap80, which is required for the normal DNA-repair function of the well-known breast cancer gene BRCA1.

The efforts of researchers at the Abramson Family Cancer Research Institute of the University of Pennsylvania and the Dana-Farber Cancer Institute, a major affiliate of Harvard Medical School, have led to this identification.

In the study, published in the journal Science, the researchers found Rap80 binds to the region of the BRCA1 protein that is necessary for recognising sites of DNA damage.

They say that cancer-causing mutations in the protein fail to bind to the Rap80 protein, disabling BRCA1 to identify DNA damage sites in the genome. As a result of this, cancer-causing mutations accumulate, spawning the development of breast and ovarian malignancies.

"With this current discovery, we have made significant new insights into the molecular mechanism by which BRCA1 recognises sites of DNA damage that breast-cancer-causing mutated forms of BRCA1 cannot recognise," says co-senior author Dr. Roger Greenberg, Assistant Professor of Cancer Biology at Penn.

"Now we have gained a partial understanding of the molecular basis between cancer-causing BRCA1 failures to fix DNA damage versus normal BRCA1s ability to fix DNA damage," he adds.

The researchers say that Rap80 enables BRCA1 to be recruited to sites of damage by binding to specific types of the ubiquitin protein, which is tightly bound to DNA.

Since BRCA1 and BRCA2 mutations account for less than 50 per cent of inherited breast cancer, boffins are of the opinion that the Rap80 gene is a candidate to investigate as another breast cancer disease gene in families that though have a history of the disease, do not have such mutations. <
'"/>




Page: 1 2

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...n for cancer, anyone? Yes, Oxford University resea...can prevent bowel cancer developing . Taking a dos...tion. Long-term aspirin use is generally not back...mach problems, but the team said it could benefit ...
...a research reveals that two thirds of those who ta...delines before doing so. In other words , those us...so on the basis of blind faith and do not care to ...ms or seek evidence based results. The researcher...
...S federal receiver Robert Sillen, hired to improve...bitious turnaround plan for his jurisdiction. Ac... the unconscionable human suffering" in prison and...es from diseases carried by inmates cycling in and...
...g man working as a cleaner for a Tasmanian school ...pturing children in the bathroom on film , and mak... of Hobart pleaded guilty to three counts of indec...child exploitation material, and one count of poss...
Other Medicine News:Health News:Aspirin can Prevent Bowel Cancer, Says UK Study 2Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3
(Date:5/15/2008)...ssure reductions demonstrated in Blacks, Hispanics...d Obese Individuals, PARSIPPANY, N.J., May 15 /PR... that data presented at the American Society of,Hy...ng (ASH 2008) in New,Orleans demonstrated that the...d olmesartan medoxomil) safely and effectively hel...
(Date:5/15/2008)...ZELL, Switzerland, May 15 /- Ergonex ... and Drug Administration (FDA) has,granted orphan ... pulmonary,arterial hypertension (PAH). Terguride ...Phase II trial in Europe., "The FDA,s grant of or...ges and strengthens our development program by off...
(Date:5/15/2008)...ble Opportunity Remains for an Antiplatelet Therap...ng than the Combination of Plavix/Iscover and ...esources, WALTHAM, Mass., May 15 /- ...earch and advisory firms for pharmaceutical and,he...ly,s Effient offers,improvement in patient compare...
(Date:5/15/2008)... Presented at the 21st Annual Meeting of The Ameri...ology (ASPHO) Meeting -, IRVINE, Calif., May 15 /...pany) (Nasdaq: IDMI ) today announced the present...program evaluating mifamurtide (L-MTP-PE) in,patie...ssion of,osteosarcoma, a rare and often fatal bone...
Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6HRSA Proposes Rule to Revise Combine HPSAs MUPs 13549 1HRSA Proposes Rule to Revise Combine HPSAs MUPs 13549 2MinuteClinic Hits 500th Clinic Mark 3B New Locations Open in Dallas Los Angeles and Orlando CVS pharmacy Stores 13545 1MinuteClinic Hits 500th Clinic Mark 3B New Locations Open in Dallas Los Angeles and Orlando CVS pharmacy Stores 13545 2MinuteClinic Hits 500th Clinic Mark 3B New Locations Open in Dallas Los Angeles and Orlando CVS pharmacy Stores 13545 3Quest Diagnostics Named to FORTUNE Magazines Americas Most Admired Companies List 3735 1Quest Diagnostics Named to FORTUNE Magazines Americas Most Admired Companies List 3735 2High Numbers of Children With Special Needs Have Health Insurance Regular Caregivers HRSA Survey Finds 13539 1High Numbers of Children With Special Needs Have Health Insurance Regular Caregivers HRSA Survey Finds 13539 2
...ystem treats female urinary stress incontinence (S...er a suprapubic (BioArcTM SP) or a transobturator ...e hybrid system combining synthetic and biologic m...ailable. The BioArc utilizes a polypropylene mesh ...
...ing System utilizes a suprapubic approach to treat...l hypermobility and/or intrinsic sphincter deficie... needles and a self-fixating sling with a resorbab...ve tension refinement without mesh distortion, as ...
...Ultra Sling is a minimally invasive treatment for ...repair surgery can be performed at the same time. ...e a sling, the In-Fast Ultra inserter is used to d...rior aspect of the pubic bone. Each screw has a su...
Proven tension-free sling technology marries with the well-researched Pelvicol® porcine acellular collagen matrix sling, for exceptional resultsby design. Natural tissue-to-tissue contact between
Medicine Products: